Stocks analysis

Analysis for ALL

  • šŸ“ˆ Growth — 22/30
  • šŸ’° Profitability — 14/20
  • šŸ¦ Financial Health — 18/20
  • šŸ’µ Valuation — 10/20
  • āš ļø Risk — 6/10
Overall Score: 70/100

Summary:


šŸ“ˆ Growth & Financial Trajectory

Across 8 quarters, Allstate’s revenue rose from about $15.714B (2024-Q2) to about $16.941B (2026-Q1), up roughly 7.8%. Net income climbed from about $0.347B to $2.458B, a multi‑fold increase, with a notable surge in late‑2025 before a softer start in 2026.

The trend is positive overall but shows quarterly volatility (e.g., 2025‑Q1 dip followed by stronger 2025‑Q3/Q4). End‑period profitability remains sensitive to cost structure and mix, yet margins improved from multi‑quarter lows to mid‑teens late in 2025 and into 2026.

šŸ’° Margins & Cash Flow

  • Operating margin ranged from about 2.7% (2024‑Q2) to about 28.4% (2025‑Q4), with several quarters in the mid‑teens, indicating substantial margin volatility but a capability to leverage scale when costs align with revenues.
  • Net cash flow from operating activities remained positive in all quarters, averaging around $3.0B per quarter; notably, 2026‑Q1 shows operating cash flow near $3.56B.
  • Investing cash flow was often negative, reflecting capital allocation and reserve considerations, while financing activity flow fluctuated, contributing to variances in overall cash balance.

šŸ›”ļø Balance Sheet & Liquidity

  • Current assets consistently exceed current liabilities, yielding a healthy current ratio around 1.3x (roughly 1.29–1.34 over periods).
  • Long‑term debt sits near $8.08B with total liabilities largely dominated by insurance reserves and operating liabilities, while equity (ā‰ˆ$21–31B across periods) provides a meaningful buffer; periods show equity around $24–31B and liabilities near $92–93B.

āš ļø Key Drivers & Risks

  • Drivers: prudent pricing and reserving practices within P&C insurance; managing catastrophe exposure and capital allocation.
  • Risks: quarterly earnings are sensitive to claim volatility and reserve adequacy; macro factors and regulatory changes can impact pricing and claims experience, affecting valuation sensitivity and downside scenarios.